HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,557,000 | +19.1% | 104,110 | +27.4% | 0.11% | +7.8% |
| Q4 2020 | $9,702,000 | +19.3% | 81,702 | -12.3% | 0.10% | +19.8% |
| Q3 2020 | $8,130,000 | -49.4% | 93,182 | -48.0% | 0.09% | -52.5% |
| Q2 2020 | $16,057,000 | +105.8% | 179,288 | +129.0% | 0.18% | +70.8% |
| Q1 2020 | $7,802,000 | -36.0% | 78,288 | -26.2% | 0.11% | -18.5% |
| Q4 2019 | $12,190,000 | -1.7% | 106,088 | +7.9% | 0.13% | -5.1% |
| Q3 2019 | $12,398,000 | -15.5% | 98,288 | -19.4% | 0.14% | -16.0% |
| Q2 2019 | $14,668,000 | +1.7% | 121,888 | -26.1% | 0.16% | +0.6% |
| Q1 2019 | $14,424,000 | -15.1% | 164,888 | -2.9% | 0.16% | -22.1% |
| Q4 2018 | $16,997,000 | -12.7% | 169,888 | 0.0% | 0.21% | +8.3% |
| Q3 2018 | $19,466,000 | +21.2% | 169,888 | -5.1% | 0.19% | +18.5% |
| Q2 2018 | $16,056,000 | -6.6% | 179,038 | -23.8% | 0.16% | -9.0% |
| Q1 2018 | $17,195,000 | +4.2% | 235,038 | -17.3% | 0.18% | +8.5% |
| Q4 2017 | $16,503,000 | – | 284,138 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |